Since our YAP/TAZ signature was enriched in cancer cells with elevated YAP/TAZ activity, we next tested whether it was predictive of YAP/TAZ-TEAD dependence in other cancer cell types, like it was in melanoma. This evidence concerns the gene WWTR1 and cancer.